{"id":"W2029038813","doi":"10.1016/j.det.2004.09.006","title":"The Use of Systemic Immune Moderators in Dermatology: An Update","year":2005,"lang":"en","type":"review","venue":"Dermatologic Clinics","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Efalizumab; Etanercept; Azathioprine; Infliximab; Dermatology; Leflunomide; Methotrexate; Immunology; Cyclophosphamide; Abatacept; Rheumatoid arthritis; Rituximab; Chemotherapy; Tumor necrosis factor alpha; Disease; Antibody; Pathology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005238703,0.0007396316,0.004866831,0.0003494413,0.0001643951,0.00006072547,0.0008050348,0.001137845,0.00002841574],"category_scores_gemma":[0.001408604,0.0004678813,0.001018464,0.0005260016,0.0004743269,0.0001614251,0.0002979544,0.001170705,0.0001532795],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000167899,"about_ca_system_score_gemma":0.001179072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001835318,"about_ca_topic_score_gemma":0.00001631424,"domain_scores_codex":[0.9932842,0.001114778,0.003868232,0.0006605973,0.0003766598,0.000695514],"domain_scores_gemma":[0.9934589,0.002102897,0.00192998,0.002147552,0.0001806424,0.0001800601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001223526,0.0007845846,0.002051177,0.01780324,0.0005594301,0.001579012,0.0001128247,0.00003947113,1.931172e-7,0.0009023066,0.002763092,0.9732823],"study_design_scores_gemma":[0.0007617924,0.0000531029,0.0001095379,0.01343301,0.001461989,0.009134825,0.00008917871,0.0007453706,6.836876e-7,0.00005840286,0.973716,0.0004361379],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002166229,0.9949611,0.00002285346,0.0002485264,0.0003892711,0.001936821,0.00007677586,0.0001573112,0.00004113098],"genre_scores_gemma":[0.003686134,0.9945557,0.000472637,0.0004266825,0.00005409338,0.0002159824,0.0004011794,0.0001135412,0.00007408543],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9728462,"threshold_uncertainty_score":0.9997773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1398703121632317,"score_gpt":0.3986714592390505,"score_spread":0.2588011470758187,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}